Sign in

CIK 0001439222

  • Large accelerated filer

AGIOS PHARMACEUTICALS, INC.

Sign in to watch
Ticker
AGIO
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 617-649-8600
Business address
88 SIDNEY STREET, CAMBRIDGE, MA, 02139
Former names
AGIOS PHARMACEUTICALS INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$371,112
in 2 filings, $371K under 10b5-1 plans

Net −$371,112. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Gheuens Sarah −$371K Chief Medical Officer sold 15% of stake

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2015-03-16 Goddard Glenn Senior Vice President, Finance Sale −10,000 $106.24 $1.1M 0
2015-03-16 Goddard Glenn Senior Vice President, Finance Exercise or conversion · Stock option (right to buy) −455 120,814
2015-03-16 Goddard Glenn Senior Vice President, Finance Exercise or conversion · Stock option (right to buy) −3,477 117,337
2015-03-16 Goddard Glenn Senior Vice President, Finance Exercise or conversion · Stock option (right to buy) −6,068 111,269
2015-03-16 Biller Scott Chief Scientific Officer Exercise or conversion +5,500 $0.47 $3K 48,270
2015-03-16 Biller Scott Chief Scientific Officer Sale −5,500 $106.81 $587K 42,770
2015-03-16 Biller Scott Chief Scientific Officer Exercise or conversion · Stock option (right to buy) −5,500 302,817
2015-03-12 Schenkein David P Chief Executive Officer Gift −190 94,511
2015-03-05 Schenkein David P Chief Executive Officer Sale −2,600 $110.16 $286K 102,501
2015-03-02 Biller Scott Chief Scientific Officer Grant or award · Stock option (right to buy) +68,000 308,317
2015-03-02 Goddard Glenn Senior Vice President, Finance Grant or award · Stock option (right to buy) +30,600 121,269
2015-03-02 Higgons John Duncan Chief Operating Officer Grant or award · Stock Option (right to buy) +68,000 365,022
2015-02-27 Biller Scott Chief Scientific Officer Grant or award +270 $39.35 $11K 42,770

Page 93 of 93 · 1,853 trades